InvestorsHub Logo

FloatServe

09/17/21 11:57 AM

#402629 RE: ATLnsider #402613

Agreed 100%. Yes exactly, we will get to see how treatment patients compare to placebo as originally designed.

There is virtually no argument to the change in SAP, and it’s almost guaranteed that the FDA has been guiding them along, as they do with all companies.